Sandeep Laumas

North Sound Capital LLC (NSC), founded by Tom McAuley, is an Old Greenwich, Connecticut-based hedge fund management firm.

Balyasny Asset Management LP (BAM) is a multi-strategy hedge fund manager and SEC-registered investment advisor headquartered in Chicago, Illinois. The firm’s predecessor, Balyasny Capital Management LLC (BCM), was founded in 2001 by Dmitry Balyasny, Scott Schroeder and Taylor O'Malley. In 2003, BCM converted from a limited liability company to a limited partnership. Then, in January 2004, their name was changed to Balyasny Asset Management LP. They are a subsidiary of Balyasny Asset Management Holdings LP. BAM provides investment advisory services to high net-worth individuals and institutional clients through privately offered pooled investment funds.

Parkway Holdings ltd. provides healthcare services. Its services include imaging, laboratory, primary care, parkway centers, and clinical research services. The company headquartered in Singapore.

SRL Ltd. engages in the provision of diagnostic services. It offers pathology and radiology testing, preventive care and clinical research, hematology and chemistry, histopathology, cytogenetic, and esoteric tests. The company was founded on July 7, 1995 and is headquartered in Gurugram, India.

Globavir Biosciences, Inc. develops therapeutics and diagnostics for the treatment of infectious diseases. The American company was founded in 2011 by Shalabh Gupta, who has been the CEO since 2011.

BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation.